Effect of liraglutide on physical performance in type 2 diabetes (LIPER2): A randomised, double-blind, controlled trial

Preclinical studies and small clinical trials suggest that glucagon-like peptide 1 (GLP1) may have a positive effect on ventricular function. Liraglutide is a GLP1-analogue used in the treatment of type 2 diabetes. LIPER2 is a phase IV, randomised, double-blind, placebo-controlled, parallel-design t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wägner, Ana María, Miranda-Calderín, Guillermo, Ugarte-Lopetegui, Miren Arantza, Marrero-Santiago, Héctor, Suárez-Castellano, Laura, Alberiche-Ruano, María del Pino, Castillo-García, Nuria, López-Madrazo, María José, Alemán, Carolina, Martínez-Mancebo, Carla, López-Ríos, Laura, Díez del Pino, Alicia, Nóvoa-Mogollón, Francisco Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935879/
https://www.ncbi.nlm.nih.gov/pubmed/29736469
http://dx.doi.org/10.1016/j.conctc.2016.06.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935879/
https://www.ncbi.nlm.nih.gov/pubmed/29736469
http://dx.doi.org/10.1016/j.conctc.2016.06.007

Ejemplares similares